COMPOSITION FOR TREATMENT OF DYSLIPIDEMIA AND INFLAMMATION
The present invention provides compositions that are substantially niacin free for treating dyslipidemia and/or inflammation in a subject. Compositions of the invention include a therapeutically effective amount of a mixture phytosomes obtained from quercetin and at least one other phytosome obtained from the group consisting of curcurmin, green tea, and a combination thereof. The present invention also provides a method for treating dyslipidemia and/or inflammation in a subject.
1 . A substantially niacin free composition for treating dyslipidemia and inflammation in a mammal, said composition comprising a therapeutically effective amount of a mixture phytosomes obtained from quercetin and at least one other phytosome obtained from the group consisting of curcurmin, green tea, and a combination thereof.
2 . The composition of claim 1 , wherein said mixture of phytosomes comprises a phytosomes obtained from quercetin and curcurmin.
3 . The composition of claim 1 , wherein said mixture of phytosomes is obtained from at least three different botanicals.
4 . The composition of claim 3 , wherein said mixture of phytosomes comprises phytosomes obtained from quercetin, curcurmin, and green tea.
5 . The composition of claim 1 , wherein said curcumin phytosome is obtained from Curcuma longa.
6 . The composition of claim 1 , wherein said green tea phytosome is obtained from Camellia sinensis.
7 . The composition of claim 1 , wherein quercetin phytosome is obtained from Sophora japonica.
8 . The composition of claim 1 , wherein said phytosome comprises a phospholipid selected from the group consisting of lecithin obtained from soy, egg, sunflower, or a combination thereof.
9 . The composition of claim 8 , wherein the amount of phospholipids in said composition ranges from about 10% to about 45%.
10 . The composition of claim 1 , wherein said composition is formulated as a soft or hard gelatin, capsule, tablet, powder, or beverage.
11 . The composition of claim 1 wherein said composition further comprises a therapeutically effective amount of a lipid-modifying composition.
12 . The composition of claim 1 , wherein the amount of said lipid-modifying composition ranges from about 1% to about 50%.
13 . The composition of claim 1 , wherein the amount of said mixture phytosomes in said composition ranges from about 1% to about 80%.
14 . A method for treating dyslipidemia or inflammation in a subject, said method comprising administering a therapeutically effective amount of a composition of claim 1 to a subject in need of such a treatment.
15 . The method of claim 14 , wherein said composition is administered orally.